Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.21
+0.01 (0.16%)
Apr 29, 2026, 1:15 PM EDT - Market open

Candel Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-38.18-55.18-37.94-18.79-36.12
Upgrade
Depreciation & Amortization
0.850.990.960.780.23
Upgrade
Other Amortization
0.360.270.320.29-
Upgrade
Loss (Gain) From Sale of Assets
0.31-0.08--
Upgrade
Asset Writedown & Restructuring Costs
0.090.040.39-0.55
Upgrade
Stock-Based Compensation
3.825.313.092.312.96
Upgrade
Other Operating Activities
-7.7421.2-0.62-16.0711.03
Upgrade
Change in Accounts Payable
0.8-0.190.05-1.210.67
Upgrade
Change in Unearned Revenue
0.18--0.190.07-0.13
Upgrade
Change in Other Net Operating Assets
1.210.53-0.381.22-1.42
Upgrade
Operating Cash Flow
-38.31-27.02-34.24-31.42-22.22
Upgrade
Capital Expenditures
-0.59-0.02-0.46-1.3-1.84
Upgrade
Sale of Property, Plant & Equipment
0.03-0.18--
Upgrade
Investing Cash Flow
-0.56-0.02-0.28-1.3-1.84
Upgrade
Long-Term Debt Issued
47.95--19.91-
Upgrade
Total Debt Issued
47.95--19.91-
Upgrade
Long-Term Debt Repaid
-11.73-9.17---
Upgrade
Total Debt Repaid
-11.73-9.17---
Upgrade
Net Debt Issued (Repaid)
36.21-9.17-19.91-
Upgrade
Issuance of Common Stock
19.89103.45-0.0671.8
Upgrade
Repurchase of Common Stock
---0.12--
Upgrade
Financing Cash Flow
56.194.28-0.1219.9771.8
Upgrade
Net Cash Flow
17.2367.24-34.65-12.7447.75
Upgrade
Free Cash Flow
-38.9-27.04-34.7-32.72-24.05
Upgrade
Free Cash Flow Margin
----26172.80%-19242.40%
Upgrade
Free Cash Flow Per Share
-0.73-0.85-1.20-1.14-1.27
Upgrade
Cash Interest Paid
1.281.82.151.15-
Upgrade
Cash Income Tax Paid
---0.180.03
Upgrade
Levered Free Cash Flow
-46.026.94-21.33-20.48-15.85
Upgrade
Unlevered Free Cash Flow
-45.067.98-20.03-19.71-15.82
Upgrade
Change in Working Capital
2.190.35-0.530.07-0.88
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.